GI disorders, gastrointestinal disorders
I will read again and mull over and I will find the link and post the article my daughter read
Studies show antioxidant support during GLP-1 therapy improves symptom tolerance, though glutathione alone doesn't eliminate side effectsproper timing and dose escalation of semaglutide do
[DOI] [PMC free article] [PubMed] [Google Scholar] 185.Borsoi F.T., Neri-Numa I.A., de Oliveira W.Q., de Arajo F.F., Pastore G.M
New recent evidence might, therefore, indicate that erythrocytes are not just mechanistically disintegrated entities but might be capable of adjusting their cell fate based on incoming life/death signals

Some possible healthcare-related risks of obesity include: Type 2 diabetes Heart disease and heart attacks Arthritis Gallbladder and fatty liver disease High cholesterol and high blood pressure Circulation problems and increase risks for stroke Infertility Osteoarthritis, in particular, the knees Sleep apnea and other breathing problems Certain kinds of cancer endometrial, breast, and colon Strain on bones, joints, and muscles due to increased weight Mobility issues Metabolic syndrome Emotional issues kidney disease and many others Semaglutide May Also Decrease Cardiometabolic Risks in Obese Patients Some medical experts predict that if obesity cases continue to rise, research has shown over the past three decades in the U.S., up to 50% of the population may be diagnosed with obesity by the year 2030